Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 8.93B | -22.61%85.18B | 12.60%110.07B | -34.29%97.75B | 43.29%148.77B | -19.79%103.82B | 102.09%129.43B | -39.12%64.05B | 33.35%105.21B | -35.83%78.9B |
Net profit before non-cash adjustment | ---15.06B | -9.00%51.7B | -29.89%56.82B | -11.68%81.04B | 105.83%91.76B | -14.69%44.58B | 57.77%52.26B | 0.26%33.12B | -51.47%33.04B | -1.56%68.08B |
Total adjustment of non-cash items | --54.28B | -41.10%32.43B | 2,213.44%55.06B | -104.06%-2.61B | -1.88%64.11B | -0.84%65.34B | 6.98%65.89B | -0.63%61.59B | 93.17%61.98B | -58.29%32.09B |
-Depreciation and amortization | --11.8B | 6.74%44.43B | 17.03%41.63B | -27.26%35.57B | -11.26%48.9B | 7.29%55.1B | 10.60%51.36B | 0.67%46.44B | -1.35%46.13B | 1.48%46.76B |
-Reversal of impairment losses recognized in profit and loss | ---- | -28.64%1.42B | -17.60%1.99B | 176.26%2.42B | -11.52%876M | -52.56%990M | -35.61%2.09B | 152.41%3.24B | 11.27%1.28B | -35.57%1.15B |
-Share of associates | --192M | -79.87%837M | 1,618.18%4.16B | -68.41%242M | -81.62%766M | -14.45%4.17B | 259.56%4.87B | 69.59%1.36B | --799M | ---- |
-Disposal profit | --0 | -901.54%-15.6B | 86.80%-1.56B | -14,850.00%-11.8B | 101.23%80M | -490.66%-6.48B | 406.09%1.66B | -67.80%-542M | -950.00%-323M | 1,050.00%38M |
-Other non-cash items | --42.29B | -84.80%1.34B | 130.43%8.84B | -315.23%-29.04B | 16.71%13.49B | 95.39%11.56B | -46.71%5.92B | -21.23%11.1B | 188.84%14.09B | -154.59%-15.87B |
Changes in working capital | ---30.29B | 157.65%1.04B | -109.34%-1.8B | 371.69%19.31B | -16.49%-7.11B | -154.10%-6.1B | 136.78%11.28B | -400.99%-30.67B | 147.91%10.19B | 8.09%-21.27B |
-Change in receivables | ---2.95B | 4.38%1.29B | 109.19%1.23B | 46.19%-13.43B | -657.53%-24.97B | 38.98%4.48B | 117.16%3.22B | -20.39%-18.77B | -1.12%-15.59B | -29.62%-15.42B |
-Change in inventory | ---- | 252.25%542M | -347.22%-356M | -90.50%144M | 315.95%1.52B | -137.97%-702M | -229.96%-295M | 1,094.74%227M | -95.98%19M | 1,128.26%473M |
-Change in payables | ---10.35B | 119.03%1B | -145.59%-5.26B | 15.06%11.54B | 185.20%10.03B | -411.96%-11.77B | 890.78%3.77B | -106.40%-477M | 181.58%7.45B | 37.70%-9.14B |
-Provision for loans, leases and other losses | ---17B | -169.50%-1.79B | -87.77%2.58B | 233.52%21.07B | 234.36%6.32B | -58.76%1.89B | 139.35%4.58B | -163.58%-11.64B | 549.49%18.31B | -18.78%2.82B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -413M | -52.22%-1.37B | -15.68%-900M | -4.99%-778M | -67.27%-741M | -10.47%-443M | -4.43%-401M | 34.02%-384M | 26.42%-582M | -19.49%-791M |
Interest received (cash flow from operating activities) | 634M | -4.93%1.85B | 9.19%1.95B | 38.83%1.78B | 18.22%1.29B | 5.74%1.09B | 10.66%1.03B | 10.99%929M | 0.00%837M | 20.09%837M |
Tax refund paid | -4.59B | -0.78%-21.32B | 54.73%-21.16B | -84.09%-46.74B | 15.47%-25.39B | -118.52%-30.03B | -6.82%-13.74B | 59.97%-12.87B | -9.96%-32.14B | 3.74%-29.23B |
Other operating cash inflow (outflow) | 0 | 0 | -1M | 0 | -1M | 0 | 1.78B | 0 | 0 | 0.00%-1M |
Operating cash flow | --4.56B | -28.48%64.33B | 72.93%89.95B | -58.02%52.02B | 66.49%123.92B | -36.97%74.43B | 128.30%118.09B | -29.45%51.73B | 47.49%73.32B | -46.32%49.72B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---12.81B | 57.70%-14.4B | 15.80%-34.04B | -34.81%-40.43B | 28.07%-29.99B | 4.87%-41.69B | -45.89%-43.83B | 28.67%-30.04B | -108.96%-42.11B | 61.07%-20.15B |
Net business purchase and sale | ---- | --1.27B | --0 | -1,410.95%-7.31B | ---484M | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | --201M | -15.47%2.7B | -71.97%3.2B | 3,261.22%11.41B | -117.15%-361M | 1,112.02%2.11B | -135.92%-208M | 102.48%579M | -1,273.52%-23.39B | -203.57%-1.7B |
Advance cash and loans provided to other parties | ---246M | -14.20%-3.64B | 42.75%-3.19B | -16.54%-5.57B | -47.76%-4.78B | -9.77%-3.24B | 35.00%-2.95B | -219.96%-4.54B | -23.30%-1.42B | 22.77%-1.15B |
Repayment of advance payments to other parties and cash income from loans | --367M | 1.60%3.99B | -40.05%3.93B | -93.30%6.56B | 5,882.81%97.82B | 30.80%1.64B | 13.33%1.25B | 7.30%1.1B | -2.93%1.03B | -26.92%1.06B |
Net changes in other investments | ---3.44B | 36.05%-12.35B | 18.14%-19.31B | -30.20%-23.59B | -107.01%-18.12B | 4.22%-8.75B | -10.40%-9.14B | -2.13%-8.28B | 2.14%-8.11B | -35.48%-8.28B |
Investing cash flow | ---15.94B | 54.60%-22.44B | 16.16%-49.42B | -233.72%-58.94B | 188.26%44.08B | 8.98%-49.94B | -33.27%-54.87B | 44.36%-41.17B | -144.79%-74B | 48.31%-30.23B |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---10B | 929.62%41.48B | 73.68%-5B | 70.99%-19B | -811.96%-65.5B | 116.16%9.2B | -141.03%-56.94B | -546.07%-23.62B | -88.97%5.3B | 21.76%48.02B |
Net common stock issuance | --0 | -399.07%-50.03B | 0.32%-10.03B | 71.83%-10.06B | -127.56%-35.71B | -392,175.00%-15.69B | ---4M | ---- | 80.00%-10.01B | -63.48%-50.01B |
Increase or decrease of lease financing | ---1.57B | -1.35%-5.77B | -0.48%-5.69B | 4.08%-5.66B | -35.20%-5.9B | -54.71%-4.37B | -9.81%-2.82B | 10.67%-2.57B | 10.35%-2.88B | 38.05%-3.21B |
Cash dividends paid | ---7.71B | 2.02%-16.43B | 14.74%-16.77B | -23.32%-19.67B | -39.53%-15.95B | -3.59%-11.43B | -3.71%-11.04B | 4.62%-10.64B | -4.50%-11.16B | -6.06%-10.68B |
Cash dividends for minorities | ---- | 91.05%-34M | -442.86%-380M | 62.77%-70M | -137.97%-188M | 44.37%-79M | -54.35%-142M | -76.92%-92M | -15.56%-52M | 44.44%-45M |
Net other fund-raising expenses | ---80M | 100.66%5M | -25,200.00%-753M | 200.00%3M | 200.00%1M | 50.00%-1M | 50.00%-2M | -125.00%-4M | 101.77%16M | -32.65%-906M |
Financing cash flow | ---19.37B | 20.30%-30.78B | 29.09%-38.62B | 55.82%-54.46B | -451.00%-123.25B | 68.47%-22.37B | -92.11%-70.95B | -96.68%-36.93B | -11.55%-18.78B | -134.84%-16.83B |
Net cash flow | ||||||||||
Beginning cash position | --194.7B | 1.45%183.23B | -25.15%180.6B | 22.69%241.28B | 1.03%196.66B | -4.05%194.65B | -11.38%202.86B | -8.16%228.93B | 0.89%249.26B | 12.61%247.05B |
Current changes in cash | ---30.74B | 480.43%11.12B | 103.12%1.92B | -237.16%-61.38B | 2,008.95%44.75B | 127.47%2.12B | 70.71%-7.73B | -35.60%-26.38B | -833.48%-19.45B | -90.17%2.65B |
Effect of exchange rate changes | --1.31B | -49.50%356M | 0.57%705M | 643.41%701M | -18.35%-129M | 77.57%-109M | -255.27%-486M | 135.49%313M | -34.86%-882M | -194.78%-654M |
Cash adjustments other than cash changes | --459M | ---- | 0.00%1M | 200.00%1M | 0.00%-1M | 0.00%-1M | ---1M | ---- | -100.47%-1M | 21,300.00%212M |
End cash Position | --165.73B | 6.26%194.7B | 1.45%183.23B | -25.15%180.6B | 22.69%241.28B | 1.03%196.66B | -4.05%194.65B | -11.38%202.86B | -8.16%228.93B | 0.89%249.26B |
Free cash flow | ---8.5B | -40.61%32.38B | 385.12%54.52B | -87.76%11.24B | 369.06%91.85B | -72.04%19.58B | 365.13%70.04B | -48.68%15.06B | 138.73%29.34B | -67.92%12.29B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |